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licenses/by-nc-nd/4.0/).Rationale & Objective: Arteriovenous fistulas are
the preferred access type for hemodialysis. The
buttonhole needling technique has become an
alternative to stepladder or area puncture. How-
ever, an increased risk for infection has been
described. The present study examined the risk for
infectious complications with different needling
techniques.
Study Design: Prospective multicenter observa-
tional cohort study with 5 years of follow-up.
Setting & Participants: In-center hemodialysis
patients from 5 hemodialysis units in Denmark,
dialyzed on a native arteriovenous fistula. 286 pa-
tients were included; 144 cannulated with the
buttonhole technique.
Exposure: The buttonhole cannulation technique
was compared to the stepladder or area puncture
technique.
Outcomes: Primary end points: event rates of
access-related Staphylococcus aureus bacteremia
and the HR for first access-related S aureus
bacteremia. Secondary end points: local
infections and access-related S aureus
bacteremia–related metastatic infections and
mortality.
Analytical Approach: Time-to-event analysis using
Cox proportional hazards regression to estimateEditorial, p. 235
Kidney Med Vol 1 | Iss 5 | September/October 2019the HR of access-related S aureus bacteremia in
buttonhole cannulation compared to stepladder/
area puncture. Poisson regression was used for
incidence rate ratio calculations.
Results: S aureus caused 48 access-related
bacteremias; 43 (90%) in the buttonhole group
compared with 5 (10%) in the stepladder/area
group. The HR for first access-related S aureus
bacteremia was significantly higher for buttonhole
cannulation compared to stepladder/area
needling (unadjusted, 6.8 [95% CI, 2.4-19.1];
adjusted, 8.4 [95% CI, 2.9-24.2]). The incidence
rate ratio for access-related S aureus bacteremia
was 6.8 (95% CI, 2.9-16.1), and the incidence
rate ratio of local cannulation-site infection
without access-related S aureus bacteremia was
3.8 (95% CI, 1.3-15.4) for buttonhole cannulation
compared to stepladder/area needling.
Limitations: Nonrandomized observational design,
prevalent hemodialysis patients.
Conclusions: Access-related S aureus bacteremia
rates were very high for buttonhole cannulation
compared to stepladder/area needling, questioning
the use of buttonhole cannulation in routine clinical
practice. A restrictive approach to buttonhole use
is recommended, with buttonhole cannulation only
being used as a second alternative to area tech-
nique when stepladder cannulation is not feasible.Arteriovenous fistulas (AVFs), when they are functional,demonstrate longer patency and fewer infectious
complications compared with central venous catheters
(CVCs) and arteriovenous grafts.1 As a consequence, AVF is
the recommended vascular access for patients treated withlong-term hemodialysis (HD).2,3
Cannulation of the AVF uses 1 of 2 methods4: either
stepladder or area technique, in which the site for needle
insertion is changed for each HD session, or buttonhole
cannulation, in which the site of needle insertion is kept
constant. Buttonhole cannulation creates a fibrous tunnel
between the skin and the vessel lumen over time, allowing
the use of blunt needles to access the fistula. The button-
hole technique was originally used for demanding fistulas
with short segments suitable for puncture, but now its use
has been extended to a wider range of HD patients; both
in-center HD and home HD (HHD) patients.Possible advantages of buttonhole cannulation, such as
longer AVF patency, fewer AVF interventions, and reduced
cannulation pain, have not been convincingly documented
because study results are inconsistent,5-8 and instead,
increasing evidence suggests that buttonhole cannulation
increases the risk for infection.6-10 A few randomized
controlled trials (RCTs) have been published with a limited
number of patients and short follow-up8,11-14; they re-
ported very low infection rates in both groups. Most
observational studies addressing the issue are retrospective
and small, with short follow-up and lack of a proper
control group, but the trend is toward a higher incidence
of AVF-related infections in buttonhole cannulation
compared to the stepladder/area cannulation technique.
Staphylococcus aureus is the leading cause of bacteremia in
HD patients15 and is associated with severe complications
such as endocarditis and osteomyelitis. The pathogen is the
main cause of infectious morbidity related to vascular ac-
cess in HD patients1 and often causes patient death.16 It has
the ability to colonize a large part of the HD population263
Original Researchwithout signs of disease but also to cause fulminant host
invasions.
The aim of this multicenter study was to compare the
risk for access-related S aureus infection in HD patients
cannulated using the buttonhole technique with patients
cannulated using the stepladder/area technique.METHODS
Study Design
We performed a prospective observational cohort study
with 5 years of follow-up enrolling patients during a 4-
month period (December 2010 to March 2011). Patients
receiving HD at 5 different HD facilities in Jutland,
Denmark (Aalborg, Aarhus, Hjoerring, Randers, and
Horsens), were assessed for eligibility. The number of
patients receiving HD in these facilities determined the
sample size.
Inclusion/Exclusion Criteria
Inclusion criteria were age older than 18 years and un-
dergoing maintenance treatment with in-center HD using
a native AVF. Exclusion criteria were presumed inability to
understand informed consent and acute kidney failure.
Data Collection
After informed consent was obtained, patients underwent
physical examination, blood sampling, and nasal swab-
bing. Blood samples were drawn from both a peripheral
vein and the arterial needle before the start of a dialysis
session. In all participants, medical history was obtained
from both patient interview and medical charts at
inclusion.
One physician (R.G.) reviewed all medical records at
study entry and during follow-up. Patients were followed
up for 5 years or censored in case of death, loss to follow-
up, kidney transplantation, change to HHD or peritoneal
dialysis, or permanent change of vascular access to arte-
riovenous graft or tunneled CVC. Clinical events were
recorded; cause and length of any hospital admission and
time and type of change in dialysis access and puncture
technique (stepladder/area cannulation or buttonhole
technique). For access-related S aureus bacteremia, meta-
static complications were recorded. Details of all access-
related infections requiring hospitalization were collected.
Outcomes
The primary outcome was access-related S aureus bacteremia.
Blood specimens for culture were routinely obtained in case
of fever or when bacteremia was suspected for other rea-
sons, and access-related S aureus bacteremia was defined as 1
or more positive blood culture with S aureus and absence of a
source of infection other than the AVF. Two successive
bacteremias in a patient were regarded as separate events
when the second bacteremia occurred more than 3 weeks
after cessation of antibiotic treatment. Survival analysis with264time to first access-related S aureus bacteremia as the outcome
measure was used to compare the risk for access-related S
aureus bacteremia with buttonhole cannulation versus step-
ladder/area fistula needling. Because cannulation tech-
niques and vascular accesses changed for several patients
during follow-up, data were split at the time of each change
for the individual patients in the final Cox regression anal-
ysis, allowing each patient to add event-free time to the new
cannulation method. In the Cox regression analysis, patients
were censored at time of first event, disregarding follow-up
time and events hereafter. For calculation of risk rates of
infection, participation time was calculated as the sum of all
AVF days for each patient according to cannulation tech-
nique; time receiving HD with a CVC was excluded.
The secondary outcome of local cannulation-site
infection requiring hospital admission was defined as
admission to the hospital with erythema, pain, warmth,
swelling, or discharge from the cannulation site deemed
by the treating clinicians to represent a local infection.
Cannulation Practices
All 5 HD facilities participating in the study offered both
buttonhole and stepladder/area cannulation technique to
HD patients. The choice of cannulation method used in a
given patient was made on the basis of a combination of
patient preference, nurse preferences, and facility trends.
There were no absolute contraindications for buttonhole
tract creation, but stepladder/area technique was often
favored in patients receiving HD fewer than 3 times per
week or in patients with previous endocarditis and/or
artificial heart valves. Buttonholes were preferred for pa-
tients preparing for HHD. All staff performing AVF can-
nulation were registered nurses. In a given patient, only 1
to 2 nurses were cannulating during buttonhole tract
creation, but in established buttonholes, no such restric-
tion was enforced.
Ethics
The study protocol was approved by the Regional Research
Ethics Committee of The North Jutland Region (protocol
N-20100041) and was conducted in accordance with the
ethical principles of the Declaration of Helsinki.
Biochemical Analyses
Blood cultures from both peripheral vein and dialysis ac-
cess were incubated and microbial growth was detected
using the BacT/ALERT system (BioMerieux). When blood
cultures flagged positive on the system, aliquots of the
blood culture medium were used to identify the cultured
organism. An S aureus isolate from each S aureus bacteremia
was referred to the national reference laboratory (Statens
Serum Institut, Copenhagen, Denmark). Nasal swabs were
tested for S aureus using routine methods. C-Reactive pro-
tein was measured using the Tina-quant CRP Gen. 3 ul-
trasensitive particle-enhanced immunoturbidimetric assay
(Roche Diagnostics GmbH).Kidney Med Vol 1 | Iss 5 | September/October 2019
Adult paents on hemodialysis in 5 different Danish facilies 
(N = 415)
Paents included 
(N = 286)
Paents enrolled in study 
(N = 292)
Paents eligible for study 
(N = 326)
Excluded:
Paents without ability to understand 
informed concent or with acute kidney failure 
(n = 39)
Did not meet inclusion criteria:
Dialyzed on tunneled central venous 
catheters (n = 42)
Dialyzed on arteriovenous gras (n = 8)
Declined to parcipate (n = 34)
Died before baseline work-up (n = 3)
Withdrew consent (n = 3)
Figure 1. Patient flow diagram depicts enrollment.
Original ResearchStatistical Analyses
Baseline data are given as mean ± standard deviation,
median with interquartile range, or percentage, as
appropriate.
Time to first access-related S aureus bacteremia was
examined using Kaplan-Meier and Cox proportional haz-
ards approaches disregarding follow-up time after the first
event. To investigate whether observed differences be-
tween groups were confounded by demographic or clin-
ical factors, the following variables were added to the Cox
model: age, sex, S aureus nasal carriage, and whether there
were any changes in cannulation technique. To test the
proportional hazards assumption, we used Schoenfeld re-
siduals and log-log plots.
We calculated the person-time incidence rate as the
number of events per total number of fistula-days (stan-
dardized to 1,000 fistula-days). Comparison of event rates
between groups was done using Poisson regression with
clustered sandwich estimation of standard errors, allowing
for correlation within each patient for recurrent events. To
the Poisson regressions, the binary variable of change in
cannulation technique was added. Difference in length of
access-related S aureus bacteremia–caused hospitals stays
was estimated using ordinary linear regression. Confidence
intervals (CIs) and P values were calculated using bootstrap
with 10,000 replications to accommodate non-normality.
Quantitative variables were handled as continuous.
Statistical analysis was performed using STATA (version
14 MP; Stata Corp), and the level of statistical significance
was set at 5%.RESULTS
Study Participants
A total of 415 patients were receiving HD in the 5 centers
at the time of inclusion, and 286 patients were finally
included (Fig 1); 144 cannulated using the buttonhole
technique, and 142, using stepladder/area needling.
All changes in cannulation technique were registered
and in total there were 205 periods with buttonhole
cannulation and 193 periods with stepladder/area cannu-
lation. Stepladder/area cannulation was used at some point
during follow-up for 173 patients, and buttonhole can-
nulation was used for 183 patients at some point (Fig S1).
The reasons for cannulation change were local infection,
access-related S aureus bacteremia, difficult cannulations,
cannulation pain, patient preference, staff preference, long
bleeding time after HD, and preparation for HHD.
Total follow-up time was 803 patient-years, 1,025 days
per participant (1,012 days excluding temporary acute or
tunneled CVCs). Mean follow-up time per period in the
buttonhole group was 783 (range, 4-1,858) days, and in
the stepladder/area group, 667 (range, 4-1,857) days.
(Censoring causes are given in Fig S2).
Participants in the buttonhole needling group were
younger with a slightly longer HD vintage compared withKidney Med Vol 1 | Iss 5 | September/October 2019stepladder/area group participants, and the HD frequency
was higher in the buttonhole group, mainly driven by
more patients in the stepladder/area group dialyzing only
twice weekly. In the stepladder/area group, there were
more men and more comorbid conditions (cancer and
cardiovascular disease) compared with the buttonhole
group (Table 1). Immunosuppressive therapy or signs of
infection were similar, and S aureus nasal carriage did not
differ between groups (40% and 43%). A description of
baseline characteristics with the cohort divided into 3
cannulation groups (buttonhole only, stepladder/area
only, and patients who switched cannulation technique
during follow-up) is found in Table S1. Ten participants in
the buttonhole group and 2 in the stepladder/area group
had positive blood cultures at baseline (Table 1). These
positive cultures were regarded as contamination, and the
involved patients showed no signs of bacteremia.
S aureus Bacteremias
During follow-up, 168 events of positive blood cultures
were found (cultured pathogens are given in Table S2).
Thirty-six patients experienced 48 episodes of access-
related S aureus bacteremia, all methicillin susceptible, and
32 of these patients were in the buttonhole group
(Table 2). Men in the buttonhole group accounted for 33
of the 43 access-related S aureus bacteremia episodes. Two
of the 19 patients in the buttonhole group and none of the
4 patients in the stepladder/area group performing self-
cannulation developed access-related S aureus bacteremia.
In total, 18 patients (16 men) developed access-related S
aureus bacteremia during the first year; 16 in the buttonhole265
Table 1. Baseline Demographic Characteristics by Puncture
Technique at Baseline
Characteristics
Buttonhole Puncture
at Baseline (N = 144)
Sharp Needle
at Baseline
(N = 142)
Age, y 63.7 (50.6-74.2) 71.2 (59.3-
79.2)
Age > 65 y 67 (47%) 91 (64%)
Male sex 86 (60%) 104 (73%)
Diabetes
No 109 (76%) 104 (73%)
Type 1 12 (8%) 7 (5%)
Type 2 23 (16%) 31 (22%)
Tobacco use
Never 51 (35%) 42 (30%)
Previous 52 (36%) 66 (46%)
Active 40 (28%) 33 (23%)
Cause of ESRD
Diabetic nephropathy 25 (17%) 24 (17%)
Glomerulonephritis 24 (17%) 13 (9%)
Vasculitis 10 (7%) 4 (3%)
Hypertension and
vascular
15 (10%) 25 (18%)
Polycystic kidney
disease
17 (12%) 12 (9%)
Uropathy 7 (5%) 14 (10%)
Other 15 (10%) 25 (18%)
Unknown 31 (22%) 25 (18%)
Previous cardiovascular
disease
60 (42%) 77 (54%)
TTRRT, y 3.9 (2.0-8.4) 3.4 (1.0-8.8)
HD vintage, y 2.8 (1.7-6.0) 2.5 (0.8-5.5)
Vascular access:
AVF ante brachium 113 (78%) 111 (78%)
AVF brachium 30 (21%) 31 (22%)
AVF femur 1 (0.7%) 0 (0%)
Self-cannulation 19 (13%) 4 (3%)
Access vintage, y 3.0 (1.5-6.0) 2.3 (1.0-5.2)
Dialysis modality
HD 119 (83%) 121 (85%)
HDF 25 (17%) 21 (15%)
HD filter
High flux 102 (71%) 76 (54%)
Low flux 42 (29%) 66 (46%)
HD frequency,
sessions/wk
<3 13 (9%) 36 (27%)
3 117 (81%) 95 (67%)
>3 14 (10%) 11 (8%)
Systolic blood
pressure, mm Hg
144 ± 26 141 ± 24
Diastolic blood
pressure, mm Hg
73 ± 15 69 ± 15
Statin treatment 44 (31%) 52 (37%)
Erythropoietin
treatment
137 (95%) 124 (87%)
Iron treatment 117 (81%) 107 (75%)
Immunosuppressive
treatment
12 (8%) 12 (9%)
(Continued)
Table 1 (Cont'd). Baseline Demographic Characteristics by
Puncture Technique at Baseline
Characteristics
Buttonhole Puncture
at Baseline (N = 144)
Sharp Needle
at Baseline
(N = 142)
Immunosuppressive
last 6 mo
5 (4%) 1 (0.7%)
Active cancer at
inclusiona
5 (4%) 14 (10%)
Previous cancera 14 (10%) 18 (13%)
C-Reactive protein,
mg/L
5.6 (1.7-12.5) 6.0 (2.8-16.5)
Antibiotics at inclusion 15 (10%) 9 (6%)
Antibiotics last mo 18 (13%) 23 (16%)
Subjective sign of
infection
28 (19%) 21 (15%)
Objective signs of
infection
12 (8%) 15 (11%)
Positive nasal swab 58 (40%) 61 (43%)
Positive blood culture,
all
10 (7%) 2 (1%)
Positive blood culture
from peripheral vein
1 (0.7%) 0 (0%)
Blood culture with
CoNS
8 (6%) 2 (1%)
Blood culture with
Staphylococcus aureus
2 (1%) 0 (0%)
Note: Values expressed as mean ± standard deviation, median (range, 25th-
75th percentiles), or number (percent).
Abbreviations: AVF, arteriovenous fistula; CoNS, coagulase-negative staphy-
lococci; ESRD, end-stage renal disease; HD, hemodialysis; HDF, hemodiafil-
tration; TTRRT, total time on renal replacement therapy.
aExcept basal cell carcinoma and squamous cell carcinoma of the skin.
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Original Researchgroup. In the buttonhole group, 69% of patients with
access-related S aureus bacteremia during the first year of
follow-up were S aureus nasal carriers at baseline, compared
to none in the stepladder/area group. The unadjusted
hazard ratio (HR) for first access-related S aureus bacteremia
for a baseline nasal carrier was 2.5 (95% CI, 1.3-4.9)
compared to a non-nasal carrier. Looking only at the
buttonhole patients, the HR was 3.0 (95% CI, 1.4-6.1).
The person-time incidence rate of access-related S aureus
bacteremia was 0.268 per 1,000 fistula-days in the
buttonhole group compared to 0.0388 in the stepladder/
area group (Table 2), giving an incidence rate ratio (IRR)
of 6.78 (95% CI, 2.85-16.14). The time to first access-
related S aureus bacteremia was significantly longer in the
stepladder/area group compared with the buttonhole
group (Fig 2). The HR for first access-related S aureus
bacteremia is shown in Table 3. The addition of HD facility
to the model increased the HR of access-related S aureus
bacteremia further (HR, 10.1 [95% CI, 3.5-29.4]). The
addition of HD frequency to the model did not alter the
coefficient of interest.
S aureus Bacteremia Complications and Local
Infections
Access-related S aureus bacteremias caused 742 in-hospital
days in the buttonhole group and 89 days in theKidney Med Vol 1 | Iss 5 | September/October 2019
Table 2. Infectious Complications by Cannulation Technique
Buttonhole
(160,556
fistula-d)
Stepladder or
Area (128,806
fistula-d)
IRR (95% CI) PN Ratea N Ratea
Bacteremia events 124 0.772 40 0.311 2.48 (1.60-3.84) <0.001
Access-related Staphylococcus aureus
bacteremia
43 0.268 5 0.0388 6.78 (2.85-16.14) <0.001
All staphylococci 82 0.511 15 0.117 4.33 (2.39-7.86) <0.001
1st access-related S aureus bacteremia 32 0.199 4 0.0311 6.46 (2.31-18.05) <0.001
Non–access-related S aureus bacteremia
cannulation-site infections requiring admission
19 0.118 4 0.0311 3.91 (1.35-11.34) 0.01
Combined access-related S aureus bacteremia
and cannulation-site infection
7 0.0436 1 0.00776 5.58 (0.68-45.54) 0.11
Metastatic access-related S aureus bacteremia
infections
8 0.0498 1 0.00776 6.46 (0.80-51.97) 0.08
Total no. of infectious endocarditis 12 0.0747 2 0.0155 4.96 (1.11-22.23) 0.04
Abbreviations: CI, confidence interval; IRR, incidence rate ratio.
aPerson-time incidence rate per 1,000 fistula-days.
0.
25
0.
50
0.
75
1.
00
144 108 87 61 49 33Buttonhole
142 97 71 51 30 23Stepladder/area
Number at risk
0 1 2 3 4 5
analysis time, years
Stepladder/area Buttonhole
Staphylococcus aureus bacteremia
Proportion free from AVF-related
P < 0.001
Figure 2. Kaplan-Meyer survival estimates. Abbreviation: AVF,
arteriovenous fistula.
Original Researchstepladder/area group, mean difference per stay was 2.04
(95% CI, 0.83-3.25) days longer in the buttonhole group,
and local cannulation-site infection without access-related
S aureus bacteremia caused 19 admissions in 16 patients in
the buttonhole group in contrast to 4 admissions in the
stepladder/area group (IRR, 3.91 [95% CI, 1.35-11.34]).
Eight buttonhole patients with access-related S aureus
bacteremia developed metastatic infections, mainly endo-
carditis (n = 7). In comparison, 1 case of endocarditis was
observed in the stepladder/area group with access-related S
aureus bacteremia. Two of 32 (6.3%) patients in the
buttonhole group and 1 of 4 (25%) in the stepladder/area
group died within 30 days of first access-related S aureus
bacteremia.
The IRR of recurrent access-related S aureus bacteremia
for AVF users was 3.2 (95% CI, 1.5-6.3) compared to first
access-related S aureus bacteremia.DISCUSSION
A functioning vascular access is regarded as the lifeline for
the HD patient. AVFs are the preferred access type due to
fewer complications compared with other types of
vascular accesses, but whether sharp or blunt needles
should be preferred is still unclear. Our study clearly
shows that the risk for infection, especially access-related S
aureus bacteremia, is significantly increased using the
buttonhole technique compared to the stepladder/area
technique. This relatively large cohort with 5-year follow-
up is one of the largest studies examining infectious
outcomes of buttonhole cannulation. With an adjusted
HR > 8 for the first access-related S aureus bacteremia and
an access-related S aureus bacteremia rate ratio of 6.8 for
buttonhole compared to stepladder/area technique, our
study confirms the results from prior observational
studies.
Previous studies have examined the incidence of S aureus
bacteremia after switching from rope-ladder technique toKidney Med Vol 1 | Iss 5 | September/October 2019buttonhole technique. In line with our results, Labriola
et al17 in a single-center study retrospectively observed a
nearly 7-fold increase in the incidence of access-related S
aureus bacteremia after a change from rope-ladder technique
to buttonhole technique in 177 in-center HD patients fol-
lowed up for 510 patient-years. In contrast, Bechade et al18
evaluated patients from a low-care dialysis unit before and
after a progressive switch from rope-ladder to buttonhole
cannulation. The reported access-related S aureus bacteremia
rate was only 0.05/1,000 patient-days in 115 patients fol-
lowed up for 268 patient-years after conversion to button-
hole technique. The IRR after/before was 2.9. However, this
small low-care unit with 6 patients dialyzing at a time and 1
attending nurse, with some patients performing self-
cannulation, is not comparable to busy larger units like ours.
In a study from London,19 a large cohort of in-center
HD patients was compared retrospectively for differences
in infectious complications between cannulation tech-
niques (and CVCs). Twelve episodes of access-related S267
Table 3. HR for Developing Staphylococcus aureus Bacteremia
Related to the Arteriovenous Fistula for Patients Using Buttonhole
Technique or a Sharp Needle for Area/Stepladder Puncture
HR 95% CI P
Sharp needle for area or
stepladder puncture
Reference
Buttonhole technique
(unadjusted)
6.76 2.39-19.13 <0.001
(adjusted) 8.41 2.93-24.15 <0.001
Note: Unadjusted and adjusted for age, sex, Staphylococcus aureus nasal
carriage, and change of cannulation method during follow-up.
Abbreviations: CI, confidence interval; HR, hazard ratio.
Original Researchaureus bacteremia were observed in 219 buttonhole patients
with 30 months of follow-up. The HR for developing
access-related S aureus bacteremia was 3.6 (95% CI, 1.3-
9.6) compared with patients using area needling. All pa-
tients were screened every 3 months for nasal carriage of S
aureus and carriers were decolonized with chlorhexidine
and/or mupirocin according to sensitivity. This eradica-
tion regimen may explain the lower rate of access-related S
aureus bacteremia compared with ours.
Four RCTs have reported on infectious outcomes in in-
center HD patients randomly assigned to buttonhole or
stepladder/area technique.11-14 In contrast to our results,
all 4 RCTs reported low S aureus bacteremia rates. One
explanation could be short follow-up time in the RCTs, but
another might be a protocol/Hawthorne effect affecting
not only participants, but also members of the staff.20 Our
study describes and reflects daily clinical practice. A larger
RCT with long follow-up might help, but recruitment can
be difficult, as seen in a recent pilot trial21 examining the
feasibility of such a study in HHD patients. The authors
succeeded in randomly assigning only 14 of 158 patients
who started HHD training.
Many studies examining HHD patients report increased
infection rates for the buttonhole technique compared to
stepladder/area needling.6,22-24 Several factors may ac-
count for this variability in the published access-related S
aureus bacteremia rates. Differences in patient characteristics,
especially when comparing in-center HD to HHD, are
numerous; there is significant between-facility variability
in access-related infection rates regardless of vascular access
type and cannulation technique,25,26 possibly reflected in
differences in clinical practices and expertise, as well as in
differences in dialysis populations. Studies with short
follow-up7,12-14 reported lower access-related S aureus
bacteremia rates, indicating that follow-up time is of
importance and accounts for some of the reported variance.
It is important to recognize what causes the increased S
aureus bacteremia rate for the in-center HD buttonhole
patients. Differences in patient characteristics and HD fre-
quency could have an impact, but in our study, the risk for
access-related S aureus bacteremia was associated only with S
aureus nasal carriage.
In our study, 69% of patients in the buttonhole group
who developed access-related S aureus bacteremia during268the first year of follow-up were S aureus nasal carriers at
baseline. This carrier status may play an important role in S
aureus bacteremia, and prophylactic approaches such as
mupirocin applied to the buttonhole site27 or nasal
mupirocin28 may be promising, although concerns of
potential mupirocin resistance must be considered.29,30 S
aureus colonizing the nares may be autoinoculated on the
skin overlying the cannulation site through the patient’s
hand.31 From the skin, buttonhole patients have a unique
route to the bloodstream through the buttonhole tract. Sato
et al32 found that a bulging deformity of the buttonhole
entry site increased the risk for vascular access–related
infection with an odds ratio of 5.4 (P = 0.0085)
compared with buttonholes with a flat entry. However, it
is unknown whether this increased risk is caused by a more
difficult scab removal or an expansion of the tract opening
due to the bulging deformity.
A study of the bacteriology of the buttonhole cannu-
lation tract recently showed that 38% of buttonhole can-
nulators had at least 1 positive culture result from the
buttonhole tract or the cannula tip on 3 monthly sets of
cultures and that 30% of those with positive tract culture
also had concomitant bacteremia (based on cultures drawn
from the access).33 During 9 months of follow-up, 60% of
participants who had cultures with S aureus or repeatedly
Staphylococcus epidermidis–positive cultures developed access-
related infections (30% bacteremia and 30% buttonhole
infection) compared to infection in 6% of culture-negative
participants. In the study by Nesrallah et al,27 they applied
mupirocin ointment to the buttonhole entry site after an
HD session, indicating that the application decolonized a
buttonhole tract that was harboring S aureus. Auto-
inoculation and possibly tract opening deformities may
enable S aureus to colonize the tract and when the equi-
librium of host resistance and bacterial inoculum is upset,
bacteremia may develop.
In our study, 30-day mortality after the first S aureus
bacteremia was relatively low in the buttonhole group
(6.3%). However, in the entire cohort, 30-day all-cause
case mortality was 8.3% (3/36). In line with our results,
Collier et al19 found a combined 30-day mortality rate of
9.7% including patients using CVCs. In a nationwide
Danish database study by Nielsen et al,34 the 30-day case
fatality after S aureus bacteremia among HD patients was
10.2% (95% CI, 8.5%-12.1%) compared to 24.2% (95 CI,
21.2%-27.6%) among population controls. Outside
Europe, reported mortality rates are higher, ranging from
20% (12-week mortality) after S aureus bacteremia in the
United States16 to 46.9% (in-hospital mortality) in
Japan.35 Thus, short-term mortality is lower in HD pa-
tients, especially those cannulating with the buttonhole
technique, compared with population controls. This might
be explained because the threshold for hospital admission
and blood culturing of dialysis patients showing signs and
symptoms compatible with S aureus bacteremia may be
lower in a hospital setting than in the general population.
Thus, early initiation of correct therapy would result inKidney Med Vol 1 | Iss 5 | September/October 2019
Original Researchimproved survival compared with population controls. The
low rate of methicillin-resistant S aureus causing S aureus
bacteremia in Denmark also leads to early correct and
effective antibiotic therapy.36
Wertheim et al37 showed that for nosocomial S aureus
bacteremia, nasal S aureus carriers had a 3-fold higher inci-
dence (80% endogenous) compared with noncarriers, but
lower in-hospital S aureus bacteremia–related mortality of
8% compared with 32% in noncarriers. This finding could
not be explained by differences in age and underlying
disease. An improved outcome in patients with S aureus
bacteremia caused by endogenous S aureus strains indicate
that the patient may have immunologically adapted to that
particular strain, hence producing a more adequate im-
mune response than noncarriers, or that exogenous strains
might be more virulent. Disputing the thought of immu-
nologic adaptation is the fact that several attempts to create
an effective anti–S aureus vaccine have failed.38
Our study has several limitations. The observational
design, though prospective, is inferior to a RCT. Patient
characteristics, especially age, differed between cannulation
groups. One would expect older patients to be at higher
risk for developing S aureus bacteremia due to immune state
and comorbid conditions. Buttonhole patients in our study
were younger than participants in the stepladder/area
group, thereby potentially underestimating the true HR.
Between-center differences in protocol, preferences, and
technique may strengthen the external validity of the study,
but comparisons may be difficult to interpret. Our multi-
center prospective cohort study had all data collected by the
same investigator, thereby minimizing bias due to differ-
ences in data interpretation and admission coding.
In conclusion, we report the largest prospective multi-
center cohort study of in-center HD patients comparing
buttonhole cannulation to stepladder/area cannulation.
Infection rates were almost 7 times higher in the button-
hole group, with an adjusted HR of time to first access-
related S aureus bacteremia of 8.4, but mortality due to
access-related S aureus bacteremia was low. The data suggest
that it might be advisable to identify and characterize the
group of patients suitable for buttonhole cannulation to
implement strict selection criteria. In our HD facilities,
buttonhole and stepladder/area cannulation techniques
have been equal first choices in in-center HD patients;
however, the results question the use of buttonhole can-
nulation as a first choice. An individual restrictive attitude is
recommended, with buttonhole as a second alternative to
area technique when stepladder cannulation is not feasible.SUPPLEMENTARY MATERIAL
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